Corrigendum to “Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase” [Antivir. Res. 218 (2023) 105716–105728, doi: 10.1016/j.antiviral.2023.105716]
-
Published:2023-11
Issue:
Volume:219
Page:105729
-
ISSN:0166-3542
-
Container-title:Antiviral Research
-
language:en
-
Short-container-title:Antiviral Research
Author:
Bennett Ryan P.,Yoluç Yasemin,Salter Jason D.,Ripp Alexander,Jessen Henning J.,Kaiser Stefanie M.,Smith Harold C.
Subject
Virology,Pharmacology